Caribou Biosciences, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Berkeley, CA
CRBU chart
What traders are saying about $CRBU
Latest postsCaribou Biosciences, Inc. news
- Phase III SYMPATICO trial: Ibrutinib + venetoclax in nonblastoid MCL
Lymphoma Hub ·
- Caribou Biosciences, Inc. Estimates – NASDAQ:CRBU
TradingView ·
- CRBU Q2 2026 Earnings: Loss Narrower Than Feared as Pre-Revenue Biotech Beats Consensus - Profit Inflection Point
https://www.dars.gov.et/ ·
- Outcomes with allo-HSCT and auto-HSCT in hepatosplenic T-cell lymphoma
Lymphoma Hub ·
- Multiple Myeloma Pipeline 2026: Who Is Leading the Race? Top
openPR.com ·
- In the hunt for reverse merger targets, Caribou could be prized game
biopharmadive.com ·
- Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
biopharmadive.com ·
- CAR-T specialist Caribou culls pipeline and seeks exit deal
pharmaceutical-technology.com ·
- CRBU Stock Crashes 35% Premarket — RBC Slashes Target By 90% After Caribou Scraps CAR-T Programs
stocktwits.com ·
- Caribou Biosciences stock plunges 40% on halt of CAR-T programs
Yahoo Finance ·
- Caribou Biosciences to Evaluate Strategic Alternatives
Yahoo Finance ·
- Caribou Biosciences (CRBU) Loses 19.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Yahoo Finance ·
Caribou Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $11.2M | $10.0M | $34.5M | $13.9M |
| Net income | -$148.1M | -$149.1M | -$102.1M | -$99.4M |
| Diluted EPS | $-1.59 | $-1.65 | $-1.38 | $-1.64 |
| Total assets (year end) | $175.4M | $313.3M | $432.2M | $373.8M |
| Cash and equivalents (year end) | $12.4M | $16.3M | $51.2M | $58.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Caribou Biosciences, Inc.
- Ticker
- CRBU (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Berkeley, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1619856
Frequently asked questions
What exchange is Caribou Biosciences, Inc. listed on?
Caribou Biosciences, Inc. trades on the Nasdaq under the ticker symbol CRBU.
What industry is Caribou Biosciences, Inc. in?
Caribou Biosciences, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Caribou Biosciences, Inc. headquartered?
Caribou Biosciences, Inc.'s business address on file with the SEC is in Berkeley, CA.
When does Caribou Biosciences, Inc.'s fiscal year end?
Caribou Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Caribou Biosciences, Inc. report?
Caribou Biosciences, Inc. reported $11.2M in revenue for calendar year 2025, according to its SEC filings.